Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 36.58M 92.63M 2023-12
Agios Pharmaceuticals USD -104874000 5.6M 2023-12
Akebia Therapeutics USD 10.78M 14.24M 2023-12
Alnylam Pharmaceuticals USD -102922000 330.12M 2023-12
Arrowhead Research USD -132282000 27.81M 2023-12
AstraZeneca USD 3.43B 412M 2023-09
Bluebird Bio USD -83657000 670K 2023-09
Bristol-Myers Squibb USD 4.89B 261M 2023-12
Eli Lilly USD 3.84B 1.88B 2023-09
Esperion Therapeutics USD -27507000 9.5M 2023-09
Halozyme Therapeutics USD 121.73M 10.37M 2023-12
Heron Therapeutics USD -24202000 17.46M 2023-09
Insmed USD -159156000 23.92M 2023-12
J&J USD 6.46B 1.51B 2023-12
Ligand Pharmaceuticals USD 5.56M 4.01M 2023-12
Merck USD 7.51B 11.02B 2023-09
Minerva Neurosciences USD -6071000 1.56M 2023-09
Moderna USD 209M 1.97B 2023-12
Pfizer USD 1.14B 2.05B 2023-12
PTC Therapeutics USD 88.72M 144.83M 2023-12
Takeda JPY 133.35B 206.72B 2023-09
Teva Pharmaceutical Industries USD 1.14B 13M 2023-09
Ultragenyx Pharmaceutical USD -137906000 4.69M 2023-09
Vanda Pharmaceuticals USD -2489000 5.16M 2023-06
Veracyte USD 2.87M 7.62M 2023-12



Vanda Pharmaceuticals - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.